Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease

Hyperphosphatemia is a risk factor for ectopic calcification and coronary artery diseases in end stage renal diseases (ESRD). The aim of this study was to assess the effect of low-dose nicotinic acid on hyperphosphatemia in patients with ESRD. This randomized, double-blind clinical trial was done on...

Full description

Bibliographic Details
Main Authors: N S Zahed, N Zamanifar, H Nikbakht
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Nephrology
Subjects:
Online Access:http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2016;volume=26;issue=4;spage=239;epage=243;aulast=Zahed